A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research

Completed

Conditions studied: SARS-CoV Infection

In brief

Minimal risk research study: 1. Comparing polyester nasal swabs and foam nasal swabs to detect SARS-CoV-2 virus; 2. Quantifying the development and trajectory of the disease through clinic visits and blood values.

Key facts

Study ID

NCT04327804

Run by

UnitedHealth Group

People needed

139

Starts

2020-03-25

Expected to finish

2020-10-10

Last updated by the study team

2022-04-11

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Existing patient of the Everett Clinic (i.e., has previously sought care)
• Tested positive for SARS-CoV-2 virus (confirmed by RT-PCR) prior to time of enrollment

You may not qualify if…

• Not able to demonstrate understanding of the study
• Not able to safely travel to the clinic without endangering themselves or risking exposing others to SARS-CoV-2
• Medical history evidencing any of the following
• Active nosebleed in the past 24 hours
• Nasal surgery in the past two weeks
• Chemotherapy treatment with low platelet and low white blood cell counts
• Acute facial trauma
• Advanced COVID-19 state that would preclude safe and feasible sample collection

Where it is running

• Everett Clinic — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.